跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Buscopan Venus
Approved
STANDARD
Buscopan Venus
Sanofi Vietnam Shareholding Company
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bdc3e00713c616fe
Company
Sanofi Vietnam Shareholding Company
Type
Standard
Approval Details
Approval Id
bdc3e00713c616fe
Drug Approval Philippines Name
Buscopan Venus
Product Name
Buscopan Venus
Registration Number
DRP-3039-01
Brand Name
Buscopan Venus
Generic Name
Hyoscine-N-Butylbromide + Paracetamol
Dosage Form
Film Coated Tablet
Dosage Strength
10 mg /500 mg
Manufacturer
Sanofi Vietnam Shareholding Company
Importer
Opella Healthcare Philippines, Inc.
Distributor
Metro Drug, Inc.
Issuance Date
29 November 2022
Expiry Date
31 May 2027
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bdc3e00713c616fe
Type
Standard
Back to Philippines FDA Approvals
Buscopan Venus - Philippines FDA Drug Approval Details